Login / Signup

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Maja LudvigsenAmanda Jessica CampbellMarie Beck EnemarkTrine Engelbrecht HybelMarja-Liisa Karjalainen-LindsbergKlaus BeiskeMette BjerreLars Møller PedersenHarald HolteSirpa LeppaJudit Meszaros JørgensenBent Honoré
Published in: Blood cancer journal (2023)
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • mass spectrometry
  • free survival
  • label free
  • single molecule